Free Trial

Valhi (VHI) Competitors

Valhi logo
$15.62 -0.13 (-0.79%)
As of 01:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VHI vs. CC, PCT, NGVT, BAK, UAN, ECVT, TROX, WLKP, ASIX, and OEC

Should you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), PureCycle Technologies (PCT), Ingevity (NGVT), Braskem (BAK), CVR Partners (UAN), Ecovyst (ECVT), Tronox (TROX), Westlake Chemical Partners (WLKP), AdvanSix (ASIX), and Orion (OEC). These companies are all part of the "chemicals" industry.

Valhi vs.

Chemours (NYSE:CC) and Valhi (NYSE:VHI) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.

Valhi has a net margin of 4.29% compared to Chemours' net margin of 1.51%. Chemours' return on equity of 26.54% beat Valhi's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours1.51% 26.54% 2.41%
Valhi 4.29%6.90%3.36%

Chemours received 404 more outperform votes than Valhi when rated by MarketBeat users. However, 63.34% of users gave Valhi an outperform vote while only 60.51% of users gave Chemours an outperform vote.

CompanyUnderperformOutperform
ChemoursOutperform Votes
639
60.51%
Underperform Votes
417
39.49%
ValhiOutperform Votes
235
63.34%
Underperform Votes
136
36.66%

Chemours currently has a consensus price target of $17.56, indicating a potential upside of 67.12%. Valhi has a consensus price target of $20.00, indicating a potential upside of 28.08%. Given Chemours' stronger consensus rating and higher probable upside, research analysts plainly believe Chemours is more favorable than Valhi.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
Valhi
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 3.3%. Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 2.0%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Valhi pays out 7.8% of its earnings in the form of a dividend.

Valhi has lower revenue, but higher earnings than Chemours. Valhi is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.79B0.27-$238M$0.2052.53
Valhi$2.11B0.21-$12.10M$4.103.81

In the previous week, Chemours had 16 more articles in the media than Valhi. MarketBeat recorded 20 mentions for Chemours and 4 mentions for Valhi. Chemours' average media sentiment score of 0.69 beat Valhi's score of 0.64 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Valhi
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Chemours has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, Valhi has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

76.3% of Chemours shares are held by institutional investors. Comparatively, 3.8% of Valhi shares are held by institutional investors. 0.5% of Chemours shares are held by insiders. Comparatively, 0.2% of Valhi shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Chemours beats Valhi on 14 of the 20 factors compared between the two stocks.

Get Valhi News Delivered to You Automatically

Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VHI vs. The Competition

MetricValhiIndustrial inorganic chemicals IndustryMaterials SectorNYSE Exchange
Market Cap$441.83M$25.17B$3.10B$19.26B
Dividend Yield2.08%3.47%5.20%3.83%
P/E Ratio5.0011.4072.4534.34
Price / Sales0.212.5125,591,212,775,269,500.0034.56
Price / Cash12.6456.3524.3417.51
Price / Book0.357.175.234.68
Net Income-$12.10M$731.97M$156.48M$1.02B
7 Day Performance1.13%-2.85%1.82%-2.66%
1 Month Performance-4.07%1.59%4.39%5.98%
1 Year Performance-17.56%-28.34%18.51%5.61%

Valhi Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VHI
Valhi
2.6801 of 5 stars
$15.62
-0.8%
$20.00
+28.1%
-18.6%$441.83M$2.11B5.002,250News Coverage
Dividend Announcement
Analyst Upgrade
CC
Chemours
4.6474 of 5 stars
$11.19
+0.2%
$17.56
+56.9%
-60.1%$1.67B$5.79B19.636,600Trending News
Dividend Announcement
Analyst Downgrade
Analyst Revision
Gap Up
High Trading Volume
PCT
PureCycle Technologies
2.1127 of 5 stars
$8.78
-5.5%
$12.00
+36.7%
+70.4%$1.58B$1.58M-5.85120Positive News
Gap Down
NGVT
Ingevity
3.3638 of 5 stars
$42.36
-1.4%
$52.75
+24.5%
-17.6%$1.54B$1.35B-3.582,050Positive News
Gap Up
BAK
Braskem
2.497 of 5 stars
$3.70
+2.5%
$9.75
+163.5%
-53.9%$1.47B$78.95B-1.048,310Positive News
UAN
CVR Partners
2.9292 of 5 stars
$83.52
+1.9%
N/A-1.9%$1.43B$540.53M14.50300Positive News
High Trading Volume
ECVT
Ecovyst
4.0338 of 5 stars
$7.24
-4.4%
$10.00
+38.1%
-21.5%$849.98M$706.15M15.74880Positive News
Gap Down
TROX
Tronox
4.7906 of 5 stars
$5.30
-2.2%
$9.64
+81.9%
-73.2%$837.07M$3.04B-17.106,610Positive News
Gap Down
High Trading Volume
WLKP
Westlake Chemical Partners
3.2669 of 5 stars
$22.73
0.0%
N/A+0.6%$800.98M$1.09B12.99150Positive News
ASIX
AdvanSix
3.9053 of 5 stars
$24.44
+4.1%
$33.50
+37.1%
+0.3%$655.31M$1.56B15.181,460Positive News
Gap Up
High Trading Volume
OEC
Orion
4.2261 of 5 stars
$11.12
-2.0%
$14.50
+30.4%
-56.6%$625.72M$1.85B14.831,600Positive News
Gap Down

Related Companies and Tools


This page (NYSE:VHI) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners